Chemplast Sanmar Limited held its Q4 & FY26 Earnings Conference Call on May 26, 2026. The transcript was submitted to the stock exchanges on June 2, 2026, at 10:00 AM IST.

Financial Performance Overview

For FY26, the company reported consolidated revenue of ₹4,224 crores and EBITDA of ₹198 crores. The net loss for the period stood at ₹280 crores. In Q4 FY26, consolidated revenue was ₹1,256 crores (9% YoY growth), with EBITDA of ₹194 crores compared to ₹37 crores in Q4 FY25. The net loss for the quarter was ₹45 crores.

Segment-wise Performance (Q4 FY26)

  • Specialty Chemicals: Revenue of ₹475 crores (13% YoY growth), with volumes up 17% YoY. Contributed 38% of total revenue.
  • Value-added Chemicals: Revenue of ₹120 crores (down from ₹169 crores YoY). Contributed 9% of total revenue.
  • Suspension PVC (CCVL): Revenue of ₹661 crores (18% YoY growth). Contributed 53% of total revenue.

Impairment and Exceptional Items

The company recorded an impairment loss of ₹898 crores against the book value of investments (₹1,556 crores) in its suspension PVC business (CCVL). This is a non-cash adjustment under Ind AS 36 due to a structural reset in earnings outlook from market challenges.

CCVL also recorded an exceptional item of ₹150 crores for FY26 towards provision for onerous contracts and write-down of raw material carrying value. This inventory write-down is expected to be reversed in FY27.

Business Environment and Challenges

FY26 was marked by persistent price pressures, excess global capacities, geopolitical disruptions, volatile feedstock/energy costs, and continued dumping of suspension PVC and paste PVC into India from China, Europe, and Japan.

The Middle East war created chaotic price situations for PVC and feedstock VCM, causing a sharp disconnect between PVC and VCM prices as Chinese carbide PVC flooded the Indian market at low prices.

Regulatory support weakened through rescinding of Quality Control Orders (QCOs) and reduction in customs duty (until June 2026). The industry expected antidumping duties, higher customs duty, or import controls which did not materialize.

Specialty Chemicals Segment

Paste PVC:

  • Cuddalore facility operated at 100% capacity throughout FY26.
  • Demand remained stable from footwear; healthy traction from automotive and upholstery.
  • Received final findings from DGTR in antidumping investigation against imports from EU and Japan. Awaiting notification by Finance Minister. Implementation expected in H1 FY27.
  • Lower import bookings from Europe already observed.

Custom Manufactured Chemicals (CMC):

  • Performance impacted by global agrochemical market slowdown, pricing pressure from Chinese generic supplies, and slower ramp-up of new molecules.
  • Early signs of recovery with strong order book for FY27.
  • 45+ molecules progressing across development stages; 17 already commercial.
  • Recruiting senior resources in Europe and Japan to accelerate business development and diversification beyond agrochemicals.

Refrigerant Gas Project:

  • Commercial production of R32 refrigerant gas commenced recently at the 2 kt swing plant in Mettur.
  • Commissioning of new plants expected in phases throughout the year.
  • Targeting 14 kt capacity by end of calendar year 2026 with design opportunities for further debottlenecking.

Value-added Chemicals Business

  • Caustic soda and chloromethanes markets remained under pressure in first two months of Q4 due to weak demand and pricing pressure.
  • Caustic soda volumes improved sequentially but remained lower YoY due to reduced production at Mettur facility during membrane change activity.
  • Temporary price spurt after war started tempering down.
  • Hydrogen peroxide and chloromethane volumes impacted by lower hydrogen/chlorine availability from reduced caustic soda output.
  • Demand from key end-user industries and pharma customers remained largely stable.

Strategic Initiatives

The Board has constituted a committee of three independent directors to examine strategic priorities for enhancing long-term value creation. The committee may evaluate potential reorganization, M&A opportunities, and engage advisers. Findings will be tabled to the Board for review and decision-making.

Debt Position

Consolidated net debt stood at ₹1,419 crores as of March 31, 2026.

Stand-alone Performance (Chemplast Sanmar)

For FY26, stand-alone revenue was ₹2,170 crores with EBITDA of ₹108 crores. Net loss stood at ₹1,003 crores after impairment provision.

Management Outlook

  • Commodity business (including CCVL) expected to face volatile near-term environment due to geopolitical developments, raw material/energy price fluctuations, and supply chain uncertainty.
  • Positive on specialty business with expected stronger performance from better fundamentals and prospects.
  • Focus remains on operational efficiency, cost optimization, capacity utilization, customer relationships, expansion project execution, and specialty portfolio enhancement.

Capital Structure Impact

The impairment represents a significant non-cash adjustment to the book value of investments but does not affect liquidity or operational capability.

Cash Flow Implications

No immediate cash flow impact from the impairment. The ₹150 crore inventory write-down is expected to reverse in FY27, providing future P&L benefit.